Responsible for identification and evaluation of novel drug targets for unmet medical needs in major disease areas (Oncology, Autoimmune), with sound scientific rationale, and coming up with proposals for promising drug targets that drive the company's R&D pipeline. Mining proprietary and public biological data/database to generate novel hypotheses or insights. Responsible for database/AI company information collection and collaboration, filter settings for identify new targets, and manage seamless connection between informatics and Neologics internal target identification &validation platform before the targets get into the portfolio. Participate in translational research that could lead to new target identification, indication expansion or new combination therapy approaches. Collaborate closely and effectively as a member of global biomarker and translational research team, follow sound scientific practices and maintain effective documentation of activities and analyses. Research and tracking identified project's IP landscape. Tracking trends, target companies, and competitors with identified projects. Delivering Innovation metrics reporting and analyses for senior management, including trend analyses and commentary on key statistics in defined timeline (monthly).
PhD degree in bioinformatics/genomics/cancer biology or autoimmune biology fields, familiar with targets. Familiarity with public databases and tools: NCBI, Ensembl, TCGA, cBioPortal, Oncomine, dbSNP, broad institute etc. Experience with open-source bioinformatics tools and packages. Self-motivated and enjoys teamworking within an international team and dynamic environment always with timeline in mind. Thorough understanding and interest in tumor biology and immunology Fast learner and excited for new challenges, programming and scripting abilities in R, and proficient in at least one other programming language (Python, Perl, Shell scripting, Java etc. is preferred.